Financial Results for the 2nd Quarter of
Fiscal Year Ending March 31, 2023 (FY2022)

from the beginning

Production & Operation Strategy to lead the success of GS26

• Safe Harbor for Forward-Looking Statements and Use of Document

• Production Strategy Transition

• Create business and regional diversity than ever before in GS26

• Improvement GP with saving COGS in GS26

• Issues and Solutions to lead the success of GS26

• Costa Rica: N. American strategic production site

• Terumo History, Future Moves

• Profitability Improvement by Consolidation in Costa Rica

• China production strategy: Rebuilding

• Reforming TIS Operation

• Business Model Change ～CAPEX for B2B～

• Key Success Factors to Achieve GS26

＠

Financial Results for the 2nd Quarter (First Half) of Fiscal Year Ending March 31, 2023 (FY2022)

• Safe Harbor for Forward-Looking Statements and Use of Document

• FY22 Q2 Results Highlights

• P&L Results

• Operating profit variance analysis (Q2)

• Operating profit variance analysis (Q2 YTD)

• Revenue by Region

• C&V: 6% growth when excluding FX.Number of procedures returned to growth trend including U.S. Segment profit remains impact of FX and inflation

• TMCS: Sales declined in Q2 due to the seventh COVID wave, Sales increase YTD Q2 Segment Profit; Decrease by inflation and FX impact bystorong CNY

• TBCT: Sales grew with double digit and profit declined because of Plasma Donation System Began Plasma donation “Rika” sales

• Action Ahead

• Dividend guidance revision

• Product Pipeline and Major Topics

Reference

• Revenue by Segment and Region

• Quarterly Trend of Revenue and Operating Profit

• P&L (QoQ)

• SG&A (QoQ)

• SG&A (YoY)

• Adjusted Operating Profit amount

• CAPEX, Depreciation and R&D Expenses

• Cash flow (Q2 YTD)

• Cash Flows

• FY22 FX Impact Breakdown (Flow, Stock)

• Foreign Exchange Sensitivity

@